Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury

Fig. 2

Characterisation of the huMSCs employed. a Spindle-shaped cells in cultures of MSCs from Wharton’s jelly. b Fluorescence-activated cell immunophenotyping analysis of huMSCs, showing positivity (for CD90, CD29, CD73, CD105 and CD44) and negativity (for human leukocyte antigen-D region (HLA-DR), CD45 and CD34). c Fluorescence-activated cell immunophenotyping analysis of aMSCs, showing positivity (for CD90, CD29, CD73, CD105 and CD44) and negativity (for HLA-DR, CD45 and CD34). d Analysis of the differentiation capacity of the huMSCs. e Analysis of the differentiation capacity of the aMSCs. f Klotho: immunoblots and densitometric analysis of samples from huMSCs (n = 2) and aMSCs (n = 4). g β-gal: immunoblots and densitometric analysis of samples from huMSCs (n = 2) and aMSCs (n = 4). a p < 0.05 vs huMSCs. aMSC adipose-derived mesenchymal stromal cell, huMSC human umbilical cord-derived mesenchymal stromal cell, β-gal β-galactosidase

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512